You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,498,445


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,498,445 protect, and when does it expire?

Patent 9,498,445 protects TALICIA and is included in one NDA.

This patent has twenty-nine patent family members in twenty-four countries.

Summary for Patent: 9,498,445
Title:Pharmaceutical compositions for the treatment of Helicobacter pylori
Abstract: Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by H. pylori or the prevention of recurrence of disorders associated with infection by H. pylori.
Inventor(s): Fathi; Reza (Oradell, NJ), Raday; Gilead (Palo Alto, CA), Goldberg; Guy (Tel Aviv, IL), Gosselin; Patrick (Laval, CA)
Assignee: RedHill Biopharma Ltd. (Tel-Aviv, IL)
Application Number:14/522,921
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,498,445: A Detailed Analysis

Introduction

Patent 9,498,445, like many other patents, is a complex document that outlines the scope and claims of an invention. To fully comprehend its implications, it is crucial to delve into the specifics of the patent, including its background, the invention itself, and the claims made.

Background of Patent 9,498,445

While the specific details of Patent 9,498,445 are not provided in the sources, understanding the general context of patents and their components is essential. Patents are granted by the U.S. Patent and Trademark Office (USPTO) and are designed to protect the intellectual property of inventors[2].

The Invention

The invention described in a patent typically involves a novel and non-obvious solution to a problem. For Patent 9,498,445, the invention would be detailed in the specification section of the patent document. This section includes descriptions, drawings, and sometimes examples that illustrate how the invention works and its intended use.

Claims

The claims section of a patent is critical as it defines the scope of the invention and what is protected by the patent. Claims are typically divided into independent and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are broad and encompass the core aspects of the invention. For example, if Patent 9,498,445 involves a new method for data processing, an independent claim might describe the overall process and key components involved[3].

Dependent Claims

Dependent claims, on the other hand, refer back to an independent claim and add additional limitations or details. These claims narrow down the scope of the invention and often provide more specific examples or variations of the independent claims.

Patent Scope and Claim Language

The scope of a patent is often measured by the breadth and clarity of its claims. Research has shown that narrower claims, as measured by independent claim length and count, are associated with a higher probability of grant and a shorter examination process[3].

Metrics for Measuring Patent Scope

  • Independent Claim Length: Longer independent claims can indicate a more detailed and specific invention, which may be easier to defend but could also limit the scope of protection.
  • Independent Claim Count: A higher number of independent claims can broaden the scope of protection but may also increase the complexity and potential for disputes.

Patent Eligibility and Recent Guidance

The USPTO's recent guidance updates, such as those introduced in 2024, are crucial for understanding how AI-related inventions, and other technologies, are evaluated for patent eligibility. This guidance emphasizes the integration of judicial exceptions into practical applications and the importance of showing concrete technological improvements[1].

Practical Applications

For a claim to be patent-eligible, it must integrate a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter.

AI-Assisted Inventions

The 2024 USPTO guidance clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies.

Examples from Recent Guidance

The USPTO has provided new examples specifically tailored to AI technologies, which can serve as a model for understanding how claims in various fields can be crafted to meet patent eligibility criteria.

Example 48: AI-Based Speech Separation

This example illustrates how claims involving AI can be patent-eligible by demonstrating a practical application. For instance, a claim that includes additional steps beyond mere data processing, such as using separated audio components in a real-time speech recognition system, can provide a tangible outcome that enhances the accuracy and functionality of the technology[1].

Impact on Patent Landscape

The clarity provided by recent USPTO guidance updates can significantly impact the patent landscape by promoting consistency and clarity in the application of patent eligibility criteria. This helps ensure that inventions, including those assisted by AI, are evaluated based on their technological contributions rather than the method of their development.

Challenges and Considerations

When drafting claims for a patent like 9,498,445, it is essential to consider several challenges and considerations:

Avoiding Abstract Ideas

Claims must avoid being classified as mere abstract ideas by ensuring they integrate judicial exceptions into practical applications. This involves demonstrating concrete technological improvements and meaningful limits on the exceptions.

Incorporating Recent Case Law

The integration of recent Federal Circuit decisions into the guidance helps practitioners stay updated with the latest legal standards and interpretations. This ensures that claims are drafted in a manner consistent with current judicial thinking.

Public Comment and Stakeholder Input

Public comments and stakeholder input, as seen in studies like the one on a small claims patent court, play a crucial role in shaping patent policies and procedures. This ensures that the patent system remains responsive to the needs of inventors and other stakeholders[5].

Key Takeaways

  • Patent Scope: The scope of a patent is critical and can be measured by the breadth and clarity of its claims.
  • Claim Language: Narrower claims with clear language are often more successful in the patent examination process.
  • Practical Applications: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility.
  • Recent Guidance: The USPTO's recent guidance updates provide clarity on patent eligibility criteria, especially for AI-related inventions.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the core aspects of the invention and stand alone without reference to other claims. They are crucial for establishing the broad scope of protection.

Q: How does the USPTO evaluate the patent eligibility of AI-related inventions?

A: The USPTO evaluates AI-related inventions based on whether they integrate judicial exceptions into practical applications and provide concrete technological improvements. The method of invention development, including the use of AI, does not impact subject matter eligibility.

Q: What metrics are used to measure patent scope?

A: Metrics such as independent claim length and independent claim count are used to measure patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process.

Q: Why is it important to incorporate recent case law into patent claims?

A: Incorporating recent case law ensures that claims are drafted in accordance with the latest legal standards and interpretations, promoting consistency and clarity in the application of patent eligibility criteria.

Q: How do public comments influence patent policies?

A: Public comments and stakeholder input help shape patent policies and procedures, ensuring the patent system remains responsive to the needs of inventors and other stakeholders.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Research and Course Guides: Patent Searching, Advanced: Overview - Clemson University
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,498,445

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y TREATMENT OF H. PYLORI INFECTION IN ADULTS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,498,445

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014216373 ⤷  Subscribe
Brazil 112015019264 ⤷  Subscribe
Canada 2900763 ⤷  Subscribe
Chile 2015002253 ⤷  Subscribe
China 105163743 ⤷  Subscribe
China 109893516 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.